<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04830475</url>
  </required_header>
  <id_info>
    <org_study_id>NIV in obese</org_study_id>
    <nct_id>NCT04830475</nct_id>
  </id_info>
  <brief_title>Non-invasive Ventilation Prevents Post-operative Respiratory Failure in Patient Undergoing Bariatric Surgery</brief_title>
  <official_title>Non-invasive Ventilation Prevents Post-operative Respiratory Failure in Patient Undergoing Bariatric Surgery: a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Campania &quot;Luigi Vanvitelli&quot;</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Campania &quot;Luigi Vanvitelli&quot;</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Postoperative non-invasive ventilation (NIV) has been proposed as an attractive strategy to&#xD;
      reduce morbidity and improve postoperative outcomes in obese subjects undergoing general&#xD;
      anesthesia. Bariatric patients present a peculiar negative feature; the increased body mass&#xD;
      index (BMI) correlates with loss of perioperative functional residual capacity (FRC),&#xD;
      expiratory reserve volume (ERV) and total lung capacity (TLC), decreased up to 50% of&#xD;
      preoperative values. The aim of the current randomized trial is to evaluate the efficacy of&#xD;
      NIV in post-anaesthesia care unit (PACU) in reducing post-extubation acute respiratory&#xD;
      failure and the consequent admission in intensive care units (ICU) after BIBP in obese adult&#xD;
      patients.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2019</start_date>
  <completion_date type="Actual">February 20, 2021</completion_date>
  <primary_completion_date type="Actual">December 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Intensive care unit admission rate</measure>
    <time_frame>72 hours</time_frame>
    <description>The primary outcome was the evaluation of the ICU admission rate after NIV in postoperative management of obese patients</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Blood oxygen saturation (SaPo2)</measure>
    <time_frame>12 hours</time_frame>
    <description>the evaluation of the oximetry values of obese patients after postoperative NIV adoption</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">90</enrollment>
  <condition>Obesity</condition>
  <condition>Postoperative Respiratory Distress</condition>
  <arm_group>
    <arm_group_label>NIV Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In poostoperative period, patients allocated in NIV Group fulfilled a 120-minute cycle of PSV + PEEP with full-face mask. Ventilation was performed with a Draeger Ventilator with the following basic settings: DeltaPInsp 10 mmHg + PEEP 5 mmHg + Fio2 60%.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>In the postoperative period, patients were offered VenturiMask with Fio2 60% at 15 l / m.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Non invasive ventilation (NIV)</intervention_name>
    <description>Patients allocated in NIV Group fulfilled a 120-minute cycle of PSV + PEEP with full-face mask. Ventilation was performed with a Draeger Ventilator with the following basic settings: DeltaPInsp 10 mmHg + PEEP 5 mmHg + Fio2 60%.</description>
    <arm_group_label>NIV Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Conventional Venturi Mask</intervention_name>
    <description>Patients were offered VenturiMask with Fio2 60% at 15 l / m.</description>
    <arm_group_label>Control Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Morbid Obesity&#xD;
&#xD;
          -  Patients undergoing Biliointestinal Bypass (BIBP)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients requiring emergency operation with rapid sequence induction&#xD;
&#xD;
          -  Patients with suspected presence of difficult airway or pre-existing lung impairment&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Asthma&#xD;
&#xD;
          -  Severe renal dysfunction,&#xD;
&#xD;
          -  cardiac disease resulting in marked limitation of physical activity, corresponding to&#xD;
             NYHA class &gt;II&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of Campania Luigi Vanvitelli</name>
      <address>
        <city>Napoli</city>
        <zip>80131</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>March 30, 2021</study_first_submitted>
  <study_first_submitted_qc>April 1, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 5, 2021</study_first_posted>
  <last_update_submitted>April 1, 2021</last_update_submitted>
  <last_update_submitted_qc>April 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Campania &quot;Luigi Vanvitelli&quot;</investigator_affiliation>
    <investigator_full_name>Claudio Gambardella</investigator_full_name>
    <investigator_title>Clinical Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Insufficiency</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>Undecided</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

